SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.130
+0.060 (1.95%)
Nov 22, 2024, 4:00 PM EST - Market closed
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $28.89 million as of November 22, 2024. Its market cap has decreased by -44.23% in one year.
Market Cap
28.89M
Enterprise Value
3.01M
1-Year Change
-44.23%
Ranking
Category
Stock Price
$3.13
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $28.89M, a decrease of -77.91%. That is a compound annual growth rate of -32.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 29.90M | -52.85% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | 130.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuCell | 28.67M |
| Daré Bioscience | 28.66M |
| DURECT | 28.56M |
| Exicure | 28.47M |
| BioVie | 28.32M |
| NeurAxis | 28.06M |
| GeoVax Labs | 28.03M |
| BriaCell Therapeutics | 27.99M |